Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Elacestrant dihydrochloride | 1349723-93-8 | 99.5% | 531.56 | 25 MG
SDP

Catalog No. 5000403164
Encompass_Preferred

Elacestrant dihydrochloride is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 nM for ERα and 870 nM for ERβ. It can also inhibit the growth of ER+ breast cancer cell lines in vitro and in vivo. This compound is designed for high-speed applications in research settings.

  • Inhibits ERα expression with an EC50 of 0.6 nM in MCF-7 cells.
  • Decreases expression of progesterone receptor in MCF7 and T47D cell lines.
  • Antagonizes E2-mediated uterine stimulation in a dose-dependent manner in vivo.
  • Induces complete tumor growth inhibition in mice.
  • Maintains tumor growth inhibition for 4 weeks after withdrawal.

Catalog No. 50-004-03164 Supplier Medchemexpress LLC Supplier No. 25MGHY19822A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Elacestrant dihydrochloride is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 nM for ERα and 870 nM for ERβ. It can also inhibit the growth of ER+ breast cancer cell lines in vitro and in vivo. This compound is designed for high-speed applications in research settings.

  • Inhibits ERα expression with an EC50 of 0.6 nM in MCF-7 cells.
  • Decreases expression of progesterone receptor in MCF7 and T47D cell lines.
  • Antagonizes E2-mediated uterine stimulation in a dose-dependent manner in vivo.
  • Induces complete tumor growth inhibition in mice.
  • Maintains tumor growth inhibition for 4 weeks after withdrawal.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.